This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Kalvista Pharmaceuticals Limited. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Innovations of Nicholas James Griffiths-Haynes
Introduction
Nicholas James Griffiths-Haynes is a notable inventor based in Warwickshire, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds.
Latest Patents
Nicholas holds a patent for "Polymorphs of n-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide as kallikrein inhibitors." This invention provides new polymorphs of the compound and its salts, along with pharmaceutical compositions containing them. These innovations are aimed at their use as kallikrein inhibitors in therapy.
Career Highlights
Nicholas is currently associated with Kalvista Pharmaceuticals Limited, where he continues to advance his research and development efforts. His work focuses on creating effective therapeutic solutions that can significantly impact patient care.
Collaborations
He has collaborated with notable colleagues such as Haydn Beaton and David Malcolm Crowe, contributing to a dynamic research environment that fosters innovation.
Conclusion
Nicholas James Griffiths-Haynes exemplifies the spirit of innovation in the pharmaceutical industry through his groundbreaking work and patents. His contributions are paving the way for new therapeutic options in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile